✦ LIBER ✦

Coronary Vasospasm with Myocardial Stunning in a Patient with Colon Cancer Receiving Adjuvant Chemotherapy with FOLFOX Regimen

✍ Scribed by Jan Cerny; Amr Hassan; Craig Smith; Bilal Piperdi

Book ID: 119935190
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 360 KB
Volume: 8
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2009.n.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4020 POSTER Efficacy and Toxicity of Adj

4020 POSTER Efficacy and Toxicity of Adjuvant FOLFOX Chemotherapy in Elderly Patients With Stage III Colon Cancer – Single Center Study

✍ Kim, J.Y.; Kim, Y.J.; Lee, K.W.; Kim, D.W.; Lee, H.S.; Kim, J.S.; Kang, S.B.; Le 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

FOLFOX-4 Regimen as First-Line Chemother

FOLFOX-4 Regimen as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer: A Safety Study

✍ Nardi, M.; Azzarello, D.; Maisano, R.; Del Medico, P.; Giannicola, R.; Raffaele, 📂 Article 📅 2007 🏛 E.S.I.F.T. S.r.l. 🌐 English ⚖ 91 KB

Adjuvant chemotherapy in elderly patient

Adjuvant chemotherapy in elderly patients with colon cancer: A single-center study in Korea

✍ Hwang, I.G.; Park, S.-E.; Jang, J.-S.; Kim, H.J.; Hong, J.Y.; Kwon, M.; Tae, J.- 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 70 KB

Prognostic Value of Mucinous Histology D

Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study

✍ Kim, Se Hyun; Shin, Sang Joon; Lee, Kang Young; Kim, Hyunki; Kim, Tae Il; Kang, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 269 KB

Prognostic Impact of Deficient DNA Misma

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

✍ Sinicrope, F. A.; Mahoney, M. R.; Smyrk, T. C.; Thibodeau, S. N.; Warren, R. S.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 240 KB

Carcinoembryonic antigen as a marker in

Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy

✍ Hèndré C. Falkson; Geoffrey Falkson; M. Antonia Portugal; Johnnie J. Van Der Wat 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Serial plasma CEA levels were determined over a period of 1-3 years in 114 patients receiving adjuvant chemotherapy for T1, 2 or 3a N+ MO breast cancer. CEA values were correlated with clinical status, scintiscans, and other biochemical parameters. CEA values >2.5 ng/ml were considered abnormal. For